CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+15.6%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$707M
AUM Growth
+$707M
(+6.9%)
Cap. Flow
-$33.7M
Cap. Flow
% of AUM
-4.77%
Top 10 Holdings %
Top 10 Hldgs %
81.61%
Holding
26
New
4
Increased
7
Reduced
9
Closed
4
Top Buys
| 1 |
United Therapeutics
UTHR
|
$44.3M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$40.3M |
| 3 |
Penumbra
PEN
|
$38.3M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$27.4M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$24.2M |
Top Sells
| 1 |
NUVA
NuVasive, Inc.
NUVA
|
$50.2M |
| 2 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
$49.2M |
| 3 |
AbbVie
ABBV
|
$47.6M |
| 4 |
AGN
Allergan plc
AGN
|
$25.5M |
| 5 |
Pacific Biosciences
PACB
|
$23.9M |
Sector Composition
| 1 | Healthcare | 88.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNK
1
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $94.8M | 13.42% | 1,560,157 +450,157 | +41% | +$27.4M |
|
|
MDVN
2
DELISTED
MEDIVATION, INC.
MDVN
| $76.6M | 10.84% | 1,270,000 -80,000 | -6% | -$4.82M |
|
|
ARIA
3
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $65.4M | 9.25% | 8,845,742 +3,270,000 | +59% | +$24.2M |
|
4
Ironwood Pharmaceuticals
IRWD
$214M
| $64.4M | 9.12% | 4,929,139 -15,000 | -0.3% | -$196K |
|
5
Orthofix Medical
OFIX
$592M
| $51.9M | 7.35% | 1,224,496 -281,400 | -19% | -$11.9M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $48.1M | 6.81% | 2,699,947 -30,000 | -1% | -$534K |
|
7
ANI Pharmaceuticals
ANIP
$2.03B
| $45.6M | 6.46% | 817,456 -210,908 | -21% | -$11.8M |
|
8
Assertio
ASRT
$80.4M
| $44.6M | 6.32% | 2,275,300 -481,060 | -17% | -$9.44M |
|
|
9
United Therapeutics
UTHR
$13.8B
| $44.3M | 6.28% | +418,700 | New | +$44.3M |
|
|
10
Penumbra
PEN
$10.6B
| $40.7M | 5.76% | 684,079 +644,079 | +1,610% | +$38.3M |
|
|
CLVS
11
DELISTED
Clovis Oncology, Inc.
CLVS
| $40.3M | 5.7% | +2,936,487 | New | +$40.3M |
|
|
EGRX
12
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $18.7M | 2.65% | 482,047 -211,890 | -31% | -$8.22M |
|
|
NXTM
13
DELISTED
NxStage Medical Inc.
NXTM
| $18.1M | 2.56% | +835,134 | New | +$18.1M |
|
|
CPHD
14
DELISTED
Cepheid Inc
CPHD
| $14M | 1.97% | +453,662 | New | +$14M |
|
|
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
| $9.87M | 1.4% | 165,203 -839,797 | -84% | -$50.2M |
|
|
16
Pacific Biosciences
PACB
$393M
| $7.84M | 1.11% | 1,114,448 -3,403,069 | -75% | -$23.9M |
|
17
ADMA Biologics
ADMA
$4.12B
| $7.58M | 1.07% | 1,273,933 +213,916 | +20% | +$1.27M |
|
18
Vericel Corp
VCEL
$1.83B
| $5.02M | 0.71% | 2,232,940 | – | – |
|
19
Axogen
AXGN
$743M
| $3.62M | 0.51% | 526,351 +120,000 | +30% | +$826K |
|
|
SPNE
20
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $2.68M | 0.38% | 255,334 +88,036 | +53% | +$923K |
|
|
BIOL
21
DELISTED
Biolase, Inc.
BIOL
| $1.47M | 0.21% | 1,257,292 +4,000 | +0.3% | +$4.68K |
|
22
Veracyte
VCYT
$2.39B
| $834K | 0.12% | 165,825 | – | – |
|
|
23
AbbVie
ABBV
$372B
| – | – | -833,000 | Closed | -$47.6M |
|
|
AGN
24
DELISTED
Allergan plc
AGN
| – | – | -95,000 | Closed | -$25.5M |
|
|
MACK
25
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| – | – | -5,875,171 | Closed | -$49.2M |
|